Stay updated on PembROlizuMab vs Chemo in MPM Clinical Trial
Sign up to get notified when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.
Latest updates to the PembROlizuMab vs Chemo in MPM Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe study has expanded to include 15 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check61 days agoChange DetectedA new study on Vorinostat in patients with advanced malignant pleural mesothelioma has been published in the Lancet Oncology journal.SummaryDifference0.1%
- Check68 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to PembROlizuMab vs Chemo in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.